Research Article
Symptoms and Severity of COVID-19 in Patients with Immune-Mediated Inflammatory Diseases: Experience of a University Medical Center
Table 2
Patient characteristics of the entire cohort.
| Characteristic | No. | % |
| Total | 156 | 100 | Inflammatory bowel disease | 117 | 75.0 | Rheumatic disease | 39 | 25.0 | Age (years) | | | Median | 42 | Mean | 46 | Range | 18–95 | Male | 67 | 42.9 | Female | 89 | 57.0 | Unvaccinated against SARS-CoV-2§ | 10 | 6.4 | Vaccinated against SARS-CoV-2§ | | | One vaccination | 143 | 91.2 | Two vaccinations | 136 | 87.2 | Three vaccinations | 113 | 72.4 | Four vaccinations | 11 | 7.1 | Self-reported history of COVID-19† | | | No | 72 | 46.2 | Yes | 81 | 51.9 |
|
|
§Data obtained by 153 patients; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; COVID-19: coronavirus disease 2019; †data obtained by 153 patients.
|